These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38007207)

  • 1. Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson's disease.
    Xiao Z; Wang X; Pan X; Xie J; Xu H
    Exp Neurol; 2024 Feb; 372():114614. PubMed ID: 38007207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing.
    Artyukhova MA; Tyurina YY; Chu CT; Zharikova TM; Bayır H; Kagan VE; Timashev PS
    Free Radic Biol Med; 2019 Nov; 144():279-292. PubMed ID: 31201850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential.
    Ding XS; Gao L; Han Z; Eleuteri S; Shi W; Shen Y; Song ZY; Su M; Yang Q; Qu Y; Simon DK; Wang XL; Wang B
    Ageing Res Rev; 2023 Nov; 91():102077. PubMed ID: 37742785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Iron Metabolism Dysfunction in Parkinson's Disease.
    Jiang H; Wang J; Rogers J; Xie J
    Mol Neurobiol; 2017 May; 54(4):3078-3101. PubMed ID: 27039308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.
    Do Van B; Gouel F; Jonneaux A; Timmerman K; Gelé P; Pétrault M; Bastide M; Laloux C; Moreau C; Bordet R; Devos D; Devedjian JC
    Neurobiol Dis; 2016 Oct; 94():169-78. PubMed ID: 27189756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JWA binding to NCOA4 alleviates degeneration in dopaminergic neurons through suppression of ferritinophagy in Parkinson's disease.
    Zhao X; Kang Z; Han R; Wang M; Wang Y; Sun X; Wang C; Zhou J; Cao L; Lu M
    Redox Biol; 2024 Jul; 73():103190. PubMed ID: 38744191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial control of cell bioenergetics in Parkinson's disease.
    Requejo-Aguilar R; Bolaños JP
    Free Radic Biol Med; 2016 Nov; 100():123-137. PubMed ID: 27091692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
    Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
    Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-related factors in the substantia nigra are associated with Parkinson's disease.
    Liu L; Cui Y; Chang YZ; Yu P
    Sci Rep; 2023 Sep; 13(1):15365. PubMed ID: 37717088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.
    Shen QQ; Jv XH; Ma XZ; Li C; Liu L; Jia WT; Qu L; Chen LL; Xie JX
    Acta Pharmacol Sin; 2024 Feb; 45(2):268-281. PubMed ID: 37674042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron as a therapeutic target for Parkinson's disease.
    Moreau C; Duce JA; Rascol O; Devedjian JC; Berg D; Dexter D; Cabantchik ZI; Bush AI; Devos D;
    Mov Disord; 2018 Apr; 33(4):568-574. PubMed ID: 29380903
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic potential of ATP-sensitive potassium channels in Parkinson's disease.
    Zhao S; Wang M; Ma Z
    Brain Res Bull; 2021 Apr; 169():1-7. PubMed ID: 33434622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
    Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders.
    Wise RM; Wagener A; Fietzek UM; Klopstock T; Mosharov EV; Zucca FA; Sulzer D; Zecca L; Burbulla LF
    Neurobiol Dis; 2022 Dec; 175():105920. PubMed ID: 36351559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
    Camilleri A; Vassallo N
    CNS Neurosci Ther; 2014 Jul; 20(7):591-602. PubMed ID: 24703487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson's Disease and Intervention with Turmeric.
    Jansen van Rensburg Z; Abrahams S; Bardien S; Kenyon C
    Mol Neurobiol; 2021 Nov; 58(11):5920-5936. PubMed ID: 34426907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
    Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.